- Nachrichtendetail
-
05.02.2024 13:18:34 - dpa-AFX: IDEXX Laboratories Expects Annual Earnings, Revenue To Climb
WASHINGTON (dpa-AFX) - IDEXX Laboratories, Inc.(IDXX), a company focused on
pet healthcare innovation, in its fourth-quarter financial report also initiated
annual guidance for earnings and revenue, which are higher than last year.
For the full-year, the company expects net income per share of $10.84 to $11.33,
up from last year's $10.06 per share.
On average, 12 analysts polled by Thomson Reuters expect the firm to earn $11
per share, for the year. Analysts' estimates typically exclude special items.
IDEXX projects annual revenue of $3.930 billion to $4.040 billion, up from last
year's $3.660 billion. Analysts, on average, expect the firm to generate revenue
of $3.97 billion.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
pet healthcare innovation, in its fourth-quarter financial report also initiated
annual guidance for earnings and revenue, which are higher than last year.
For the full-year, the company expects net income per share of $10.84 to $11.33,
up from last year's $10.06 per share.
On average, 12 analysts polled by Thomson Reuters expect the firm to earn $11
per share, for the year. Analysts' estimates typically exclude special items.
IDEXX projects annual revenue of $3.930 billion to $4.040 billion, up from last
year's $3.660 billion. Analysts, on average, expect the firm to generate revenue
of $3.97 billion.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
IDEXX LABS INC. DL-,10 | 888210 | Frankfurt | 455,100 | 26.04.24 08:02:26 | -4,000 | -0,87% | 0,000 | 0,000 | 455,100 | 455,100 |
